Abstract
Current RNA-based therapeutics are principally focused toward activating the RNA interference (RNAi) pathway through exogenous administration of short interfering RNAs (siRNAs) and sometimes short hairpin RNAs (shRNAs). The promise of RNAi-based therapeutics arises from their broad applicability and excellent specificity. This chapter reviews siRNA design strategies for improving intracellular interactions with the RNAi pathway proteins as well as key characteristics required for the design of optimal delivery vehicles to maximize specific silencing in only the cells of interest. The status of previous and ongoing clinical trials will be described as these provide insight for overcoming future challenges for long-term use of RNAi as a therapeutic modality.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akinc A, Thomas M, Klibanov AM, Langer R (2005) Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med 7(5):657–663. doi:10.1002/jgm.696
Akinc A, Zumbuehl A, Goldberg M, Leshchiner ES, Busini V, Hossain N, Bacallado SA, Nguyen DN, Fuller J, Alvarez R, Borodovsky A, Borland T, Constien R, de Fougerolles A, Dorkin JR, Jayaprakash KN, Jayaraman M, John M, Koteliansky V, Manoharan M, Nechev L, Qin J, Racie T, Raitcheva D, Rajeev KG, Sah DWY, Soutschek J, Toudjarska I, Vornlocher HP, Zimmermann TS, Langer R, Anderson DG (2008) A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol 26(5):561–569. doi:10.1038/nbt1402
Aleku M, Schultz P, Keil O, Santel A, Schaeper U, Dieckhoff B, Janke O, Endruschat J, Durieux B, Roder N, Loffler K, Lange C, Fechtner M, Mopert K, Fisch G, Dames S, Arnold W, Jochims K, Giese K, Wiedenmann B, Scholz A, Kaufmann J (2008) Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression. Cancer Res 68(23):9788–9798. doi:10.1158/0008--5472.CAN-08--2428
Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappa B by Toll-like receptor 3. Nature 413(6857):732–738. doi:10.1038/35099560
Alvarez R, Elbashir S, Borland T, Toudjarska I, Hadwiger P, John M, Roehl I, Morskaya SS, Martinello R, Kahn J, Van Ranst M, Tripp RA, DeVincenzo JP, Pandey R, Maier M, Nechev L, Manoharan M, Kotelianski V, Meyers R (2009) RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy. Antimicrob Agents Chemother 53(9):3952–3962. doi:10.1128/aac.00014--09
Alvarez-Erviti L, Seow YQ, Yin HF, Betts C, Lakhal S, Wood MJA (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29(4):341–345. doi:10.1038/nbt.1807
Ameres SL, Martinez J, Schroeder R (2007) Molecular basis for target RNA recognition and cleavage by human RISC. Cell 130(1):101–112. doi:10.1016/j.cell.2007.04.037
Andersen MO, Nygaard JV, Burns JS, Raarup MK, Nyengaard JR, Bunger C, Besenbacher F, Howard KA, Kassem M, Kjems J (2010) siRNA nanoparticle functionalization of nanostructured scaffolds enables controlled multilineage differentiation of stem cells. Mol Ther 18(11):2018–2027. doi:10.1038/mt.2010.166
Bain JR, Schisler JC, Takeuchi K, Newgard CB, Becker TC (2004) An adenovirus vector for efficient RNA interference-mediated suppression of target genes in insulinoma cells and pancreatic islets of Langerhans. Diabetes 53(9):2190–2194. doi:10.2337/diabetes.53.9.2190
Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215–233. doi:10.1016/j.cell.2009.01.002
Bernstein E, Caudy AA, Hammond SM, Hannon GJ (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409(6818):363–366. doi:10.1038/35053110
Bevilacqua PC, Cech TR (1996) Minor-groove recognition of double-stranded RNA by the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR. Biochemistry 35(31):9983–9994. doi:10.1021/bi9607259
Birmingham A, Anderson E, Sullivan K, Reynolds A, Boese Q, Leake D, Karpilow J, Khvorova A (2007) A protocol for designing siRNAs with high functionality and specificity. Nat Protoc 2(9):2068–2078. doi:10.1038/nprot.2007.278
Bohula EA, Salisbury AJ, Sohail M, Playford MP, Riedemann J, Southern EM, Macaulay VM (2003) The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript. J Biol Chem 278(18):15991–15997. doi:10.1074/jbc.M300714200
Bramsen JB, Laursen MB, Damgaard CK, Lena SW, Babu BR, Wengel J, Kjems J (2007) Improved silencing properties using small internally segmented interfering RNAs. Nucleic Acids Res 35(17):5886–5897. doi:10.1093/nar/gkm548
Bramsen JB, Laursen MB, Nielsen AF, Hansen TB, Bus C, Langkjaer N, Babu BR, Hojland T, Abramov M, Van Aerschot A, Odadzic D, Smicius R, Haas J, Andree C, Barman J, Wenska M, Srivastava P, Zhou C, Honcharenko D, Hess S, Muller E, Bobkov GV, Mikhailov SN, Fava E, Meyer TF, Chattopadhyaya J, Zerial M, Engels JW, Herdewijn P, Wengel J, Kjems J (2009) A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity. Nucleic Acids Res 37(9):2867–2881. doi:10.1093/nar/gkp106
Brown KM, Chu C-Y, Rana TM (2005) Target accessibility dictates the potency of human RISC. Nat Struct Mol Biol 12(5):469–470. doi:10.1038/nsmb931
Burke RS, Pun SH (2008) Extracellular barriers to in Vivo PEI and PEGylated PEI polyplex-mediated gene delivery to the liver. Bioconjug Chem 19(3):693–704. doi:10.1021/bc700388u
Buyens K, Lucas B, Raemdonck K, Braeckmans K, Vercammen J, Hendrix J, Engelborghs Y, De Smedt SC, Sanders NN (2008) A fast and sensitive method for measuring the integrity of siRNA-carrier complexes in full human serum. J Control Release 126(1):67–76. doi:10.1016/j.jconrel.2007.10.024
Cardoso ALC, Simoes S, de Almeida LP, Pelisek J, Culmsee C, Wagner E, de Lima MCP (2007) SiRNA detivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing. J Gene Med 9(3):170–183. doi:10.1002/jgm.1006
Chang CI, Lee TY, Dua P, Kim S, Li CJ, Lee D-K (2011) Long double-stranded rna-mediated rna interference and immunostimulation: long interfering double-stranded rna as a potent anticancer therapeutics. Oligonucleotides 21(3):149–155. doi:10.1089/nat.2011.0296
Cho YW, Kim JD, Park K (2003) Polycation gene delivery systems: escape from the endosomes to the cytosol. J Pharm Pharmacol 55:721–734
Cho EC, Zhang Q, Xia YN (2011) The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat Nanotechnol 6(6):385–391. doi:10.1038/nnano.2011.58
Chu C-Y, Rana TM (2008) Potent RNAi by short RNA triggers. RNA 14(9):1714–1719. doi:10.1261/rna.1161908
Cockrell AS, Kafri T (2007) Gene delivery by lentivirus vectors. Mol Biotechnol 36(3):184–204. doi:10.1007/s12033--007--0010--8
Coura RD, Nardi NB (2007) The state of the art of adeno-associated virus-based vectors in gene therapy. Virol J 4. doi:10.1186/1743--422x-4--99
Dande P, Prakash TP, Sioufi N, Gaus H, Jarres R, Berdeja A, Swayze EE, Griffey RH, Bhat B (2006) Improving RNA interference in mammalian cells by 4′-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2′-O-alkyl modifications. J Med Chem 49(5):1624–1634. doi:10.1021/jm050822c
Dannull J, Lesher DT, Holzknecht R, Qi WN, Hanna G, Seigler H, Tyler DS, Pruitt SK (2007) Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity. Blood 110(13):4341–4350. doi:10.1182/blood-2007--04--083188
Dausend J, Musyanovych A, Dass M, Walther P, Schrezenmeier H, Landfester K, Mailander V (2008) Uptake mechanism of oppositely charged fluorescent nanoparticles in hela cells. Macromol Biosci 8(12):1135–1143. doi:10.1002/mabi.200800123
Davidson BL, McCray PB (2011) Current prospects for RNA interference-based therapies. Nat Rev Genet 12(5):329–340. doi:10.1038/nrg2968
Davis ME (2009) The first targeted delivery of sirna in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol Pharm 6(3):659–668. doi:10.1021/mp900015y
Dejneka NS, Wan SH, Bond OS, Kornbrust DJ, Reich SJ (2008) Ocular biodistribution of bevasiranib following a single intravitreal injection to rabbit eyes. Mol Vis 14(116–19):997–1005
Diebold SS, Kaisho T, Hemmi H, Akira S, Reise Sousa C (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303(5663):1529–1531. doi:10.1126/science.1093616
Diebold SS, Massacrier C, Akira S, Paturel C, Morel Y, Reise Sousa C (2006) Nucleic acid agonists for toll-like receptor 7 are defined by the presence of uridine ribonucleotides. Eur J Immunol 36(12):3256–3267. doi:10.1002/eji.200636617
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001a) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411(6836):494–498. doi:10.1038/35078107
Elbashir SM, Lendeckel W, Tuschl T (2001b) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15(2):188–200. doi:10.1101/gad.862301
Feinstein E (2011) Prevention and treatment of acute renal failure and other kidney diseases by inhibition of p53 by siRNA. 7910566
Frank F, Sonenberg N, Nagar B (2010) Structural basis for 5'-nucleotide base-specific recognition of guide RNA by human AGO2. Nature 465(7299):818–822. doi:10.1038/nature09039
Gantier MP, Williams BRG (2007) The response of mammalian cells to double-stranded RNA. Cytok Growth Fact Rev 18(5–6):363–371. doi:10.1016/j.cytogfr.2007.06.016
Gao GP, Alvira MR, Wang LL, Calcedo R, Johnston J, Wilson JM (2002) Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 99(18):11854–11859. doi:10.1073/pnas.182412299
Ghosh SS, Gopinath P, Ramesh A (2006) Adenoviral vectors—a promising tool for gene therapy. Appl Biochem Biotechnol 133(1):9–29. doi:10.1385/abab:133:1:9
Goodchild A, Nopper N, King A, Doan T, Tanudji M, Arndt GM, Poidinger M, Rivory LP, Passioura T (2009) Sequence determinants of innate immune activation by short interfering RNAs. BMC Immunol 10:40. doi:10.1186/1471--2172--10--40
Gorden KB, Gorski KS, Gibson SJ, Kedl RM, Kieper WC, Qiu XH, Tomai MA, Alkan SS, Vasilakos JP (2005) Synthetic TLR Agonists reveal functional differences between human TLR7 and TLR8. J Immunol 174(3):1259–1268
Gredell JA, Berger AK, Walton SP (2008) Impact of target mRNA structure on siRNA silencing efficiency: a large-scale study. Biotechnol Bioeng 100(4):744–755. doi:10.1002/bit.21798
Gredell JA, Dittmer MJ, Wu M, Chan C, Walton SP (2010) Recognition of siRNA asymmetry by TAR RNA binding protein. Biochemistry 49(14):3148–3155. doi:10.1021/bi902189s
Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, Marion P, Salazar F, Kay MA (2006) Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441(7092):537–541. doi:10.1038/nature04791
Guo PX, Coban O, Snead NM, Trebley J, Hoeprich S, Guo SC, Shu Y (2010a) Engineering RNA for targeted siRNA delivery and medical application. Adv Drug Deliv Rev 62(6):650–666. doi:10.1016/j.addr.2010.03.008
Guo ST, Huang YY, Jiang QA, Sun Y, Deng LD, Liang ZC, Du QA, Xing JF, Zhao YL, Wang PC, Dong AJ, Liang XJ (2010b) Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte. ACS Nano 4(9):5505–5511. doi:10.1021/nn101638u
Hammond SM, Bernstein E, Beach D, Hannon GJ (2000) An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404(6775):293–296. doi:10.1038/35005107
Hansen BJ, Westergaard M, Frieden M, Hansen HF, Kjaerulff LS, Thrue CA, Wissenbach MH, Dalby LW, Kearney P, Oerum O (2006) SPC2996-A Bcl-2 RNA antagonist being studied in chronic lymphocytic leukemia. J Clin Oncol 24:6610
Hartman ZC, Appledorn DM, Amalfitano A (2008) Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications. Virus Res 132(1–2):1–14. doi:10.1016/j.virusres.2007.10.005
Hickerson RP, Smith FJD, Reeves RE, Contag CH, Leake D, Leachman SA, Milstone LM, McLean WHI, Kaspar RL (2008) Single-nucleotide-specific siRNA targeting in a dominant-negative skin model. J Investig Dermatol 128(3):594–605. doi:10.1038/sj.jid.5701060
Hom C, Lu J, Liong M, Luo HZ, Li ZX, Zink JI, Tamanoi F (2010) Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells. Small 6(11):1185–1190. doi:10.1002/smll.200901966
Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S, Noronha A, Manoharan M, Akira S, de Fougerolles A, Endres S, Hartmann G (2005) Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 11(3):263–270. doi:10.1038/nm1191
Hornung V, Ellegast J, Kim S, Brzózka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann K-K, Schlee M, Endres S, Hartmann G (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314(5801):994–997. doi:10.1126/science.1132505
Hossbach M, Gruber J, Osborn M, Weber K, Tuschl T (2006) Gene silencing with siRNA duplexes composed of target-mRNA-complementary and partially palindromic or partially complementary single-stranded siRNAs. RNA Biol 3(2):82–89
Huesken D, Lange J, Mickanin C, Weiler J, Asselbergs F, Warner J, Meloon B, Engel S, Rosenberg A, Cohen D, Labow M, Reinhardt M, Natt F, Hall J (2005) Design of a genome-wide siRNA library using an artificial neural network. Nat Biotechnol 23(8):995–1001. doi:10.1038/nbt1118
Hutvagner G (2005) Small RNA asymmetry in RNAi: function in RISC assembly and gene regulation. FEBS Lett 579(26):5850–5857. doi:10.1016/j.febslet.2005.08.071
Ishihara S, Haga H, Yasuda M, Mizutani T, Kawabata K, Shirato H, Nishioka T (2010) Integrin beta 1-dependent invasive migration of irradiation-tolerant human lung adenocarcinoma cells in 3D collagen matrix. Biochem Biophys Res Commun 396(3):651–655. doi:10.1016/j.bbrc.2010.04.150
Ivanov AI, Hopkins AM, Brown GT, Gerner-Smidt K, Babbin BA, Parkos CA, Nusrat A (2008) Myosin II regulates the shape of three-dimensional intestinal epithelial cysts. J Cell Sci 121(11):1803–1814. doi:10.1242/jcs.015842
Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5(10):987–995. doi:10.1038/ni1112
Jackson AL, Linsley PS (2010) Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov 9(1):57–67. doi:10.1038/nrd3010
Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G, Linsley PS (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21(6):635–637. doi:10.1038/nbt831
Jimenez AI, Sesto A, Gascon I, Roman JP, Gonzalez de Buitrago G (2011) Methods and compositions for the treatment of eye disorders with increased intraocular pressure. 7902169, 8 Mar 2011
Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS (2007) The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol 20(1):108–119. doi:10.1038/modpathol.3800725
Judge A, Maclachlan I (2008) Overcoming the innate immune response to small interfering RNA. Hum Gene Ther 19(2):111–124. doi:10.1089/hum.2007.179
Judge AD, Sood V, Shaw JR, Fang D, McClintock K, MacLachlan I (2005) Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 23(4):457–462. doi:10.1038/nbt1081
Kaiser J (2007) Clinical research: death prompts a review of gene therapy vector. Science 317(5838):580. doi:10.1126/science.317.5838.580
Kalina WV, Gershwin LJ (2004) Progress in defining the role of RSV in allergy and asthma: from clinical observations to animal models. Clin Dev Immunol 11(2):113–119. doi:10.1080/10446670410001722131
Karikó K, Bhuyan P, Capodici J, Weissman D (2004) Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J Immunol 172(11):6545–6549
Katas H, Alpar HO (2006) Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release 115(2):216–225. doi:10.1016/j.jconrel.2006.07.021
Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, Matsushita K, Hiiragi A, Dermody TS, Fujita T, Akira S (2008) Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205(7):1601–1610. doi:10.1084/jem.20080091
Khvorova A, Reynolds A, Jayasena SD (2003) Functional siRNAs and miRNAs exhibit strand bias. Cell 115(2):209–216. doi:10.1016/S0092--8674(03)00801--8
Kim D-H, Longo M, Han Y, Lundberg P, Cantin E, Rossi JJ (2004) Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat Biotechnol 22(3):321–325. doi:10.1038/nbt940
Kiryu H, Terai G, Imamura O, Yoneyama H, Suzuki K, Asai K (2011) A detailed investigation of accessibilities around target sites of siRNAs and miRNAs. Bioinformatics 27(13):1788–1797. doi:10.1093/bioinformatics/btr276
Kodym R, Kodym E, Story MD (2009) 2′-5′-Oligoadenylate synthetase is activated by a specific RNA sequence motif. Biochem Biophys Res Commun 388(2):317–322. doi:10.1016/j.bbrc.2009.07.167
Kok KH, Ng MHJ, Ching YP, Jin DY (2007) Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA. J Biol Chem 282(24):17649–17657. doi:10.1074/jbc.M611768200
Kretschmer-Kazemi Far R, Sczakiel G (2003) The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides. Nucleic Acids Res 31(15):4417–4424. doi:10.1093/nar/gkg649
Krieg AM (2011) Is RNAi dead? Mol Ther 19(6):1001–1002. doi:10.1038/mt.2011.94
Kwon EJ, Bergen JM, Pun SH (2008) Application of an HIV gp41-derived peptide for enhanced intracellular trafficking of synthetic gene and siRNA delivery vehicles. Bioconjug Chem 19(4):920–927. doi:10.1021/bc700448h
Leachman SA, Hickerson RP, Hull PR, Smith FJD, Milstone LM, Lane EB, Bale SJ, Roop DR, McLean WHI, Kaspar RL (2008) Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita. J Dermatol Sci 51(3):151–157. doi:10.1016/j.jdermsci.2008.04.003
Leader S, Kohlhase K (2002) Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999. Pediatr Infect Dis J 21(7):629–632. doi:10.1097/00006454--200207000--00005
Lee Y, Hur I, Park SY, Kim YK, Suh MR, Kim VN (2006) The role of PACT in the RNA silencing pathway. EMBO J 25(3):522–532. doi:10.1038/sj.emboj.7600942
Lee SH, Bae KH, Kim SH, Lee KR, Park TG (2008) Amine-functionalized gold nanoparticles as non-cytotoxic and efficient intracellular siRNA delivery carriers. Int J Pharm 364(1):94–101. doi:10.1016/j.ijpharm.2008.07.027
Lee JS, Green JJ, Love KT, Sunshine J, Langer R, Anderson DG (2009) Gold, Poly(Beta-Amino Ester) nanoparticles for small interfering RNA delivery. Nano Lett 9(6):2402–2406. doi:10.1021/nl9009793
Lee S, Shim G, Kim S, Kim YB, Kim CW, Byun Y, Oh YK (2011) Enhanced transfection rates of small-interfering RNA using dioleylglutamide-based magnetic lipoplexes. Oligonucleotides 21(3):165–172. doi:10.1089/nat.2010.0274
Lei YG, Ng QKT, Segura T (2010) Two and three-dimensional gene transfer from enzymatically degradable hydrogel scaffolds. Microsc Res Tech 73(9):910–917. doi:10.1002/jemt.20840
Leuschner PJF, Ameres SL, Kueng S, Martinez J (2006) Cleavage of the siRNA passenger strand during RISC assembly in human cells. EMBO Rep 7(3):314–320. doi:10.1038/sj.embor.7400637
Lima WF, Murray H, Nichols JG, Wu H, Sun H, Prakash TP, Berdeja AR, Gaus HJ, Crooke ST (2009) Human Dicer binds short single-strand and double-strand RNA with high affinity and interacts with different regions of the nucleic acids. J Biol Chem 284(4):2535–2548. doi:10.1074/jbc.M803748200
Liu Q (2003) R2D2, a bridge between the initiation and effector steps of the drosophila RNAi pathway. Science 301(5641):1921–1925. doi:10.1126/science.1088710
Liu Y-J (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23:275–306. doi:10.1146/annurev.immunol.23.021704.115633
Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song J-J, Hammond SM, Joshua-Tor L, Hannon GJ (2004) Argonaute2 Is the catalytic engine of mammalian RNAi. Sci Signal 305(5689):1437. doi:10.1126/science.1102513
Liu XD, Howard KA, Dong MD, Andersen MO, Rahbek UL, Johnsen MG, Hansen OC, Besenbacher F, Kjems J (2007) The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials 28(6):1280–1288. doi:10.1016/j.biomaterials.2006.11.004
Liu Y, Ye X, Jiang F, Liang C, Chen D, Peng J, Kinch LN, Grishin NV, Liu Q (2009) C3PO, an endoribonuclease that promotes RNAi by facilitating RISC activation. Science 325(5941):750–753. doi:10.1126/science.1176325
Lu ZJ, Mathews DH (2008a) Efficient siRNA selection using hybridization thermodynamics. Nucleic Acids Res 36(2):640–647. doi:10.1093/nar/gkm920
Lu ZJ, Mathews DH (2008b) Efficient siRNA selection using hybridization thermodynamics. Nucleic Acids Res 36(2):640–647. doi:10.1093/nar/gkm920
Lu JJ, Langer R, Chen JZ (2009) A novel mechanism is involved in cationic lipid-mediated functional siRNA delivery. Mol Pharm 6(3):763–771. doi:10.1021/mp900023v
Lu W, Zhang GD, Zhang R, Flores LG, Huang Q, Gelovani JG, Li C (2010) Tumor site-specific silencing of NF-kappa B p65 by targeted hollow gold nanosphere-mediated photothermal transfection. Cancer Res 70(8):3177–3188. doi:10.1158/0008--5472.can-09--3379
Lynn DM, Langer R (2000) Degradable poly(beta-amino esters): synthesis, characterization, and self-assembly with plasmid DNA. J Am Chem Soc 122(44):10761–10768. doi:10.1021/ja0015388
Malathi K, Dong B, Gale M, Silverman RH (2007) Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448(7155):816–819. doi:10.1038/nature06042
Malone RW, Felgner PL, Verma IM (1989) CATIONIC liposome-mediated RNA transfection. Proc Natl Acad Sci USA 86(16):6077–6081. doi:10.1073/pnas.86.16.6077
Manche L, Green SR, Schmedt C, Mathews MB (1992) Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol Cell Biol 12(11):5238–5248
Mao SR, Neu M, Germershaus O, Merkel O, Sitterberg J, Bakowsky U, Kissel T (2006) Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes. Bioconjug Chem 17(5):1209–1218. doi:10.1021/bc060129j
Marques JT, Devosse T, Wang D, Zamanian-Daryoush M, Serbinowski P, Hartmann R, Fujita T, Behlke MA, Williams BR (2006) A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol 24(5):559–565. doi:10.1038/nbt1205
Mathews D, Sabina J, Zuker M, Turner D (1999) Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol 288(5):911–940. doi:10.1006/jmbi.1999.2700
Matranga C, Tomari Y, Shin C, Bartel DP, Zamore PD (2005) Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell 123(4):607–620. doi:10.1016/j.cell.2005.08.044
Matveeva OV, Kang Y, Spiridonov AN, Saetrom P, Nemtsov VA, Ogurtsov AY, Nechipurenko YD, Shabalina SA (2010) Optimization of duplex stability and terminal asymmetry for shRNA design. PLoS One 5(4):e10180. doi:10.1371/journal.pone.0010180
Medina-Kauwe LK, Xie J, Hamm-Alvarez S (2005) Intracellular trafficking of nonviral vectors. Gene Ther 12(24):1734–1751. doi:10.1038/sj.gt.3302592
Meng HA, Liong M, Xia TA, Li ZX, Ji ZX, Zink JI, Nel AE (2010) Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 4(8):4539–4550. doi:10.1021/nn100690m
Meyers R (2010) Methods and compostions for prevention or treatment of RSV infection using modified duplex RNA molecules. WO 2010/048590 A1, 29 Apr 2010
Meyers R (2011) RNAi modulation of RSV and therapeutic uses thereof. US Patent 7,981,869 B2, 19 July 2011
Minks MA, Benvin S, Maroney PA, Baglioni C (1979) Metabolic stability of 2′S’oligo (A) and activity of 2′ S’oligo (A)-dependent endonuclease in extracts of interferon-treated and control HeLa cells. Nucleic Acids Res 6(2):767–780
Miyoshi K, Tsukumo H, Nagami T, Siomi H, Siomi MC (2005) Slicer function of Drosophila argonautes and its involvement in RISC formation. Genes Dev 19(23):2837–2848. doi:10.1101/gad.1370605
Nguyen J, Steele TWJ, Merkel O, Reul R, Kissel T (2008) Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy. J Control Release 132(3):243–251. doi:10.1016/j.jconrel.2008.06.010
Noland CL, Ma E, Doudna JA (2011) siRNA repositioning for guide strand selection by human Dicer complexes. Mol cell 43(1):110–121. doi:10.1016/j.molcel.2011.05.028
Nykänen A, Haley B, Zamore PD (2001) ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 107(3):309–321. doi:10.1016/S0092--8674(01)00547--5
Overhoff M, Alken M, Far RK-K, Lemaitre M, Lebleu B, Sczakiel G, Robbins I (2005) Local RNA target structure influences siRNA efficacy: a systematic global analysis. J Mol Biol 348(4):871–881. doi:10.1016/j.jmb.2005.03.012
Patel PC, Hao L, Yeung WSA, Mirkin CA (2011) Duplex end breathing determines serum stability and intracellular potency of siRNA-Au NPs. Mol Pharm 8:6
Patzel V, Rutz S, Dietrich I, Koberle C, Scheffold A, Kaufmann SHE (2005) Design of siRNAs producing unstructured guide-RNAs results in improved RNA interference efficiency. Nat Biotechnol 23(11):1440–1444. doi:10.1038/nbt1151
Peebles RS Jr (2004) Viral infections, atopy, and asthma: is there a causal relationship? J Allergy Clin Immunol 113(1 Suppl):S15–S18. doi:10.1016/j.jaci.2003.10.033
Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reise Sousa C (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314(5801):997–1001. doi:10.1126/science.1132998
Pollack A (2011) Drugmakers’ fever for the power of RNA interference has cooled. New York Times, 8 Feb 2011
Portis AM, Carballo G, Baker GL, Chan C, Walton SP (2010) Confocal microscopy for the analysis of siRNA delivery by polymeric nanoparticles. Microsc Res Tech 73(9):878–885. doi:10.1002/jemt.20861
Psarras S, Papadopoulos NG, Johnston SL (2004) Pathogenesis of respiratory syncytial virus bronchiolitis-related wheezing. Paediatr Respir Rev 5(Suppl A):S179–S184. doi:10.1016/s1526-–0542(04)90034-–6
Raeber GP, Lutolf MP, Hubbell JA (2005) Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. Biophys J 89(2):1374–1388. doi:10.1529/biophysj.104.050682
Rand TA, Petersen S, Du F, Wang X (2005) Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell 123(4):621–629. doi:10.1016/j.cell.2005.10.020
Ren T, Song YK, Zhang G, Liu D (2000) Structural basis of DOTMA for its high intravenous transfection activity in mouse. Gene Ther 7(9):764–768. doi:10.1038/sj.gt.3301153
Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A (2004) Rational siRNA design for RNA interference. Nat Biotechnol 22(3):326–330. doi:10.1038/nbt936
Rivas FV, Tolia NH, Song JJ, Aragon JP, Liu JD, Hannon GJ, Joshua-Tor L (2005) Purified Argonaute2 and an siRNA form recombinant human RISC. Nat Struct Mol Biol 12(4):340–349. doi:10.1038/nsmb918
Robbins M, Judge A, MacLachlan I (2009) siRNA and innate immunity. Oligonucleotides 19(2):89–101. doi:10.1089/oli.2009.0180
Rosi NL, Giljohann DA, Thaxton CS, Lytton-Jean AKR, Han MS, Mirkin CA (2006) Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312(5776):1027–1030. doi:10.1126/science.1125559
Rozema DB, Lewis DL, Wakefield DH, Wong SC, Klein JJ, Roesch PL, Bertin SL, Reppen TW, Chu Q, Blokhin AV, Hagstrom JE, Wolff JA (2007) Dynamic polyconjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc Natl Acad Sci USA 104(32):12982–12987. doi:10.1073/pnas.0703778104
Rubin SD (2009) OPKO health announces update on phase III clinical trial of Bevasiranib
Sakurai K, Amarzguioui M, Kim D-H, Alluin J, Heale B, M-s S, Gatignol A, Behlke MA, Rossi JJ (2011) A role for human Dicer in pre-RISC loading of siRNAs. Nucleic Acids Res 39(4):1510–1525. doi:10.1093/nar/gkq846
Samuel-Abraham S, Leonard JN (2010) Staying on message: design principles for controlling nonspecific responses to siRNA. FEBS J 277(23):4828–4836. doi:10.1111/j.1742--4658.2010.07905.x
Sashital DG, Doudna JA (2010) Structural insights into RNA interference. Curr Opin Struct Biol 20(1):90–97. doi:10.1016/j.sbi.2009.12.001
Schlee M, Hartmann G (2010) The chase for the RIG-I ligand—recent advances. Mol Ther 18(7):1254–1262. doi:10.1038/mt.2010.90
Schlee M, Hornung V, Hartmann G (2006) siRNA and isRNA: two edges of one sword. Mol Ther 14(4):463–470. doi:10.1016/j.ymthe.2006.06.001
Schlee M, Roth A, Hornung V, Hagmann CA, Wimmenauer V, Barchet W, Coch C, Janke M, Mihailovic A, Wardle G, Juranek S, Kato H, Kawai T, Poeck H, Fitzgerald KA, Takeuchi O, Akira S, Tuschl T, Latz E, Ludwig J, Hartmann G (2009) Recognition of 5′-triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31(1):25–34. doi:10.1016/j.immuni.2009.05.008
Schubert S, Grünweller A, Erdmann VA, Kurreck J (2005) Local RNA target structure influences siRNA efficacy: systematic analysis of intentionally designed binding regions. J Mol Biol 348(4):883–893. doi:10.1016/j.jmb.2005.03.011
Schwarz D, Hutvagner G, Du T, Xu Z, Aronin N, Zamore P (2003) Asymmetry in the assembly of the RNAi enzyme complex. Cell 115(2):199–208
Seitz H, Tushir J, Zamore P (2011) A 5′-uridine amplifies miRNA/miRNA* asymmetry in Drosophila by promoting RNA-induced silencing complex formation. Silence 2:1–10
Seow Y, Wood MJ (2009) Biological gene delivery vehicles: beyond viral vectors. Mol Ther 17(5):767–777. doi:10.1038/mt.2009.41
Shabalina SA, Spiridonov AN, Ogurtsov AY (2006) Computational models with thermodynamic and composition features improve siRNA design. BMC Bioinforma 7:65. doi:10.1186/1471--2105--7--65
Shao Y, Chan CY, Maliyekkel A, Lawrence CE, Roninson IB, Ding Y (2007) Effect of target secondary structure on RNAi efficiency. RNA 13(10):1631–1640. doi:10.1261/rna.546207
Shen J, Samul R, Silva RL, Akiyama H, Liu H, Saishin Y, Hackett SF, Zinnen S, Kossen K, Fosnaugh K, Vargeese C, Gomez A, Bouhana K, Aitchison R, Pavco P, Campochiaro PA (2006) Suppression of ocular neovascularization with siRNA targeting of VEGF receptor 1. Gene Ther 13(3):225–234. doi:10.1038/sj.gt.3302641
Shim MS, Kwon YJ (2010) Efficient and targeted delivery of siRNA in vivo. FEBS J 277(23):4814–4827. doi:10.1111/j.1742--4658.2010.07904.x
Siegwart DJ, Whitehead KA, Nuhn L, Sahay G, Cheng H, Jiang S, Ma M, Lytton-Jean A, Vegas A, Fenton P, Levins CG, Love KT, Lee H, Cortez C, Collins SP, Li YF, Jang J, Querbes W, Zurenko C, Novobrantseva T, Langer R, Anderson DG (2011) Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery. Proc Natl Acad Sci USA. doi:10.1073/pnas.1106379108
Singerman L (2009) Combination therapy using the small interfering RNA bevasiranib. Retina-J Retin Vitr Dis 29(6):S49–S50
Sioud M (2005) Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J Mol Biol 348(5):1079–1090. doi:10.1016/j.jmb.2005.03.013
Sioud M (2006) Innate sensing of self and non-self RNAs by toll-like receptors. Trends Mol Med 12(4):167–176. doi:10.1016/j.molmed.2006.02.004
Sioud M (2007) RNA interference and innate immunity. Adv Drug Deliver Rev 59(2–3):153–163. doi:10.1016/j.addr.2007.03.006
Sonawane ND, Szoka FC, Verkman AS (2003) Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem 278(45):44826–44831. doi:10.1074/jbc.M308643200
Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, Elbashir S, Geick A, Hadwiger P, Harborth J, John M, Kesavan V, Lavine G, Pandey RK, Racie T, Rajeev KG, Rohl I, Toudjarska I, Wang G, Wuschko S, Bumcrot D, Koteliansky V, Limmer S, Manoharan M, Vornlocher HP (2004) Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432(7014):173–178. doi:10.1038/nature03121
Stevens TP, Hall CB (2004) Controversies in palivizumab use. Pediatr Infect Dis J 23(11):1051–1052. doi:10.1097/01.inf.0000145759.71531.d8
Sun X, Rogoff HA, Li CJ (2008) Asymmetric RNA duplexes mediate RNA interference in mammalian cells. Nat Biotechnol 26(12):1379–1382. doi:10.1038/nbt.1512
Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21(1):335–376. doi:10.1146/annurev.immunol.21.120601.141126
Tang MX, Redemann CT, Szoka FC (1996) In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem 7(6):703–714. doi:10.1021/bc9600630
Thery C (2011) Exosomes: secreted vesicles and intercellular communications. F1000 Biology Reports 3
Tomari Y, Du T, Haley B, Schwarz D, Bennett R, Cook H, Koppetsch B, Theurkauf W, Zamore P (2004a) RISC assembly defects in the Drosophila RNAi mutant armitage. Cell 116(6):831–841
Tomari Y, Matranga C, Haley B, Martinez N, Zamore PD (2004b) A protein sensor for siRNA asymmetry. Science 306(5700):1377–1380. doi:10.1126/science.1102755
Ui-Tei K, Naito Y, Takahashi F, Haraguchi T, Ohki-Hamazaki H, Juni A, Ueda R, Saigo K (2004) Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res 32(3):936–948. doi:10.1093/nar/gkh247
Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):U654–U672. doi:10.1038/ncb1596
van de Water FM, Boerman OC, Wouterse AC, Peters JGP, Russel FGM, Masereeuw R (2006) Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules. Drug Metab Dispos 34(8):1393–1397. doi:10.1124/dmd.106.009555
Veiseh O, Kievit FM, Mok H, Ayesh J, Clark C, Fang C, Leung M, Arami H, Park JO, Zhang MQ (2011) Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery. Biomaterials 32(24):5717–5725. doi:10.1016/j.biomaterials.2011.04.039
Ventre K, Randolph AG (2007) Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database of Syst Rev (1):Cd000181. doi:10.1002/14651858.CD000181.pub3
Vickers TA, Koo S, Bennett CF, Crooke ST, Dean NM, Baker BF (2003) Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J Biol Chem 278(9):7108–7118. doi:10.1074/jbc.M210326200
Walton SP, Wu M, Gredell JA, Chan C (2010) Designing highly active siRNAs for therapeutic applications. FEBS J 277(23):4806–4813. doi:10.1111/j.1742--4658.2010.07903.x
Wang HW, Noland C, Siridechadilok B, Taylor DW, Ma EB, Felderer K, Doudna JA, Nogales E (2009) Structural insights into RNA processing by the human RISC-loading complex. Nat Struct Mol Biol 16(11):1148–1153. doi:10.1038/nsmb.1673
Weitzer S, Martinez J (2007) The human RNA kinase hClp1 is active on 3′ transfer RNA exons and short interfering RNAs. Nature 447(7141):222–227. doi:10.1038/nature05777
Whitehead KA, Langer R, Anderson DG (2009) Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 8(2):129–138. doi:10.1038/nrd2742
Whitehead KA, Sahay G, Li GZ, Love KT, Alabi CA, Ma M, Zurenko C, Querbes W, Langer R, Anderson DG (2011) Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery. Mol Ther:7. doi:10.1038/mt.2011.141
Xiang SL, Fruehauf J, Li CJ (2006) Short hairpin RNA-expressing bacteria elicit RNA interference in mammals. Nat Biotechnol 24(6):697–702. doi:10.1038/nbt1211
Xiong XB, Uludag H, Lavasanifar A (2009) Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery. Biomaterials 30(2):242–253. doi:10.1016/j.biomaterials.2008.09.025
Ye X, Huang N, Liu Y, Paroo Z, Huerta C, Li P, Chen S, Liu Q, Zhang H (2011) Structure of C3PO and mechanism of human RISC activation. Nat Struct Mol Biol 18(6):650–657. doi:10.1038/nsmb.2032
Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5(7):730–737. doi:10.1038/ni1087
Yoshinari K, Miyagishi M, Taira K (2004) Effects on RNAi of the tight structure, sequence and position of the targeted region. Nucleic Acids Res 32(2):691–699. doi:10.1093/nar/gkh221
Zamora MR, Budev M, Rolfe M, Gottlieb J, Humar A, DeVincenzo J, Vaishnaw A, Cehelsky J, Albert G, Nochur S, Gollob JA, Glanville AR (2011) RNA interference therapy in lung transplant patients infected with respiratory syncytial virus. Am J Respir Crit Care Med 183(4):531–538. doi:10.1164/rccm.201003--0422OC
Zamore PD, Tuschl T, Sharp PA, Bartel DP (2000) RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101(1):25–33. doi:10.1016/S0092--8674(00)80620--0
Zhang H, Kolb FA, Brondani V, Billy E, Filipowicz W (2002a) Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP. EMBO J 21(21):5875–5885
Zhang LQ, Peeples ME, Boucher RC, Collins PL, Pickles RJ (2002b) Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol 76(11):5654–5666. doi:10.1128/jvi.76.11.5654--5666.2002
Zhang H, Kolb FA, Jaskiewicz L, Westhof E, Filipowicz W (2004) Single processing center models for human Dicer and bacterial RNase III. Cell 118(1):57–68. doi:10.1016/j.cell.2004.06.017
Zhang SB, Zhao B, Jiang HM, Wang B, Ma BC (2007) Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release 123(1):1–10. doi:10.1016/j.jconrel.2007.07.016
Zhang HY, Lee MY, Hogg MG, Dordick JS, Sharfstein ST (2010) Gene delivery in three-dimensional cell cultures by superparamagnetic nanoparticles. ACS Nano 4(8):4733–4743. doi:10.1021/nn9018812
Zhou XM, Rowe RG, Hiraoka N, George JP, Wirtz D, Mosher DF, Virtanen I, Chernousov MA, Weiss SJ (2008) Fibronectin fibrillogenesis regulates three-dimensional neovessel formation. Genes Dev 22(9):1231–1243. doi:10.1101/gad.1643308
Zintchenko A, Philipp A, Dehshahri A, Wagner E (2008) Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. Bioconjug Chem 19(7):1448–1455. doi:10.1021/bc800065f
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Malefyt, A.P., Angart, P.A., Chan, C., Walton, S.P. (2012). siRNA Therapeutic Design: Tools and Challenges. In: Mallick, B., Ghosh, Z. (eds) Regulatory RNAs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-22517-8_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-22517-8_19
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-22516-1
Online ISBN: 978-3-642-22517-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)